🇺🇸 FDA
Patent

US 11311549

Corticotropin releasing factor receptor antagonists

granted A61KA61K31/5377A61K31/573

Quick answer

US patent 11311549 (Corticotropin releasing factor receptor antagonists) held by SPRUCE BIOSCIENCES, INC. expires Mon Apr 21 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
SPRUCE BIOSCIENCES, INC.
Grant date
Tue Apr 26 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 21 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K31/5377, A61K31/573, A61K9/14, A61K9/48